phrykt

Bioforce Nanosciences Holdings, Inc. (BFNH): who owns it and who trades it

As of Oct 30, 2026, BFNH insiders reported 1 open-market sale worth $534K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Merle Ferguson (Director), with $534K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, BFNH insiders reported $0 of open-market purchases and $534K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$534K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Apr 22, 2026
Filed Sep 2, 2026

Purchases and sales by month

$534K$534KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Apr 22, 2026Merle FergusonDirectorSale26.70M$0.02$534KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Merle FergusonDirector–$534KApr 22, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BFNH short interest

Low short interest. Less than 0.1% of BFNH shares are sold short. Over the last 10 reports the number of shares short went up 676%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 5,430 BFNH shares were sold short, 0.0% of the shares outstanding, up 99.4% from the report before. At the average daily volume of 15,872 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.02%May 15Oct 300.02%

Days to cover

1.0May 15Oct 301.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20265,4300.02%+99%15,8721.0
Oct 15, 20262,7230.01%+17%13,1141.0
Sep 30, 20262,3200.01%-67%24,4231.0
Sep 15, 20267,0840.02%+769%48,9951.0
Aug 31, 20268150.00%+882%11,3761.0
Aug 14, 2026830.00%-92%14,6151.0
Jul 31, 20261,0000.00%–7,7021.0
Jun 30, 20269010.00%+120%22,6881.0
Jun 15, 20264100.00%–17,9971.0
May 15, 20267000.00%–3,0271.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Bioforce Nanosciences Holdings company events

Bioforce Nanosciences Holdings filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (control). The latest was on Oct 7, 2026.

  1. Oct 7, 2026AnnouncementBioforce Nanoscience, Inc. received an assignment from the State of Texas’ General Land Office on a certain oil and gas property, covering approximately 40.19 acres of land in Liberty County, Texas. Filing
  2. Sep 4, 2026SharesSold new shares outside a public offering. Filing
  3. Aug 18, 2026AnnouncementShared information with investors. Filing
  4. Aug 14, 2026Announcement– VOLUNTARY DISCLOSURE OF OTHER EVENTS BioForce NanoScience Holdings, Inc. has a group of individuals who are its Officers, Board of Directors, and Advisory Board Members. Filing
  5. Jul 7, 2026Announcement– VOLUNTARY DISCLOSURE OF OTHER EVENTS As previously reported, Bioforce Nanoscience, Inc. (Bioforce or BFNH) received the assignment of federal oil and gas leases from Natural Minerals Trust, LLC, a Delaware limited liability company, which is controlled by Nexus Capital Investments, Inc., the… Filing
  6. Jul 1, 2026Announcement– VOLUNTARY DISCLOSURE OF OTHER EVENTS On June 5, 2026 Bioforce Nanoscience, Inc. ( “Bioforce” or “BFNH”) received an assignment of federal oil and gas leases covering approximately 19,957 acres of land located in the White River Valley, Nye County, Nevada from Natural Minerals Trust, LLC, a… Filing
  7. Jun 18, 2026Control- CHANGES IN CONTROL OF THE REGISTRANT April 15, 2026, Merle Ferguson, a current Director of the Company sold 26,700,000 shares of his common stock in the Company to Nexus Capital Investments, Inc., a Delaware Corporation. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Bioforce Nanosciences Holdings financials

Questions about Bioforce Nanosciences Holdings, Inc. (BFNH) stock

Are BFNH insiders buying or selling?

In the last 12 months, BFNH insiders reported no open-market purchases and 1 sale worth $534K. The latest trade was on Apr 22, 2026. See every trade.

What is the short interest in BFNH?

As of Oct 30, 2026, 5,430 BFNH shares were sold short, 0.0% of the shares outstanding, up 99.4% from the report before. At the average daily volume of 15,872 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.